🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

"What if I told you that if you have Parkinson’s disease and you exercise regularly, there could be some serious benefits!" - Michael Okun, MD | Parkinson's Disease Neurologist To learn more, visit the #MediflixParkinsons page: mediflix.com/topics/parkins… Michael Okun #Mediflix

New Lancet article which summaries the developments in the understanding of parkinsons in the last 20 years thelancet.com/journals/laneu… Parkinson's UK Parkinson's UK Scotland Parkinson's UK Excellence Network North of Scotland Parkinsons Research Interest Grp

Delighted tspeaking about living #parkinsonsdisease @EUneurology event tomorrow. You can still register online & raise your voice for our needs as #womenlivingwithneurologicalconditions. Parkinson's Europe 🌷 Frances Fitzgerald Neurological Alliance of Ireland Parkinson's Ireland Women’s Parkinson’s Project MyMovesMatter

It's world #movementdisorders day! MDS Parkinson & Movement Disorder Alliance Parkinson's Foundation michaeljfox.org Davis Phinney FND Women Neurologists Group PD Avengers WPC 2026 Shout out to Richelle Flanagan 💚💚💚💚 & Moro Elena - Speaking to the MEP - #women #parkinsons Women’s Parkinson’s Project youtube.com/watch?v=iPHD-_…

Very grateful to the team of @UCLouvain_be for helping us make our research findings more accessible to non-specialists with these types of articles! 🧠 🙏🏼🤓🫶🏼Gerard Derosiere DuqueLab InSilicoBiology 👩🏼‍⚕️👨🏼‍🔬🧑🏽‍⚕️

Un lien établi entre des altérations du contrôle moteur et la maladie de Parkinson dailyscience.be/08/12/2022/un-…

Barber et al. show that patients with REM sleep behaviour disorder with established dopaminergic deficits have blunted pupillary responses to reward. Pupillary reward sensitivity may therefore be a marker of prodromal dopaminergic decline. bit.ly/3EEGsvM

12 scientific abstracts will be selected for “Hot Topics” WPC 2026 to present your work in front of up to 1,000 people, including many of the leaders in the field.Deadline 13.1.23 wpc2023.org/page/callabstr… Bas Bloem Michael Okun Indu Subramanian

"If data on childhood trauma and Parkinson's can be replicated, we must ask why?" "Reminder: how important obtaining a complete life history can be when strategizing on a plan. Life experiences matter and can impact symptoms." medscape.com/viewarticle/98… jamanetwork.com/journals/jaman…

Moving, fast and slow: Excellent review by Damian Herz and Peter Brown on #Parkinson bradykinesia from the perspective of behavioral modelling and control and utility theory. Is Parkinson's disease bradykinesia the result of changed effort cost computations?

"I feel passionately about spreading the word to the general public that Parkinson’s isn’t a disease that just affects older people." Tizzy is 27 and was diagnosed with Parkinson’s at the age of 25 and had originally investigated symptoms when she was 21. This is her story 👇🏽

The ICNeuromodulation Charité lab is hiring a medical doctor for European Research Council (ERC) #StG on #reinforcement effects of #deepbrainstimulation in #Parkinson disease at Charité - Universitätsmedizin Berlin. Come discover how we support instead of disrupt brain circuit activity with #DBS, #ECoG & #MachineLearning.

PD folks your voices matter. EPA pledges action on TCE! "The collective evidence association between TCE exposure+#Parkinsons accumulating. Many research groups examining the association and we anticipate more information will be available soon." foxnews.com/health/is-park…

Excited to see my entire newsfeed celebrating this. I think this could turn out to become the historical „NeuroImage event“ that changed publishing in the Neuro community. Elsevier Wiley Neuro Springer Nature take note!

If you’re around, you’re invited to join this talk by Prof. Ignacio Obeso at @UCLouvain_be this Friday! 🤓

Tomorrow, Doctor Anna Latorre will visit us at @UCLouvain_be. Join us in person, if you are around, or let me know if you would be interested in having the link to join her talk online! 🤓 DuqueLab #movementdisorders #neuromodulation #TMS

Everyone is excited about the potential for psychedelic treatment of Parkinson's and neurodegenerative diseases. Read this new piece JAMA Psychiatry which outlines the challenges including the need for the treatment to be available to 'all.' 'Classic psychedelics like psilocybin,

Airborne particulate matter pollution associated w/ dementia, new JAMA Internal Medicine study and guess what the author suggest there may be interventions to reduce pollutants may decrease your lifetime risk. However, folks we need to stop putzing around and start now to save ours